CLINICAL_TRIALS
trial_result
· 2023-11-28
Clinical Trial Update: Bisantrene Combination for Resistant AML [Phase 2]
Summary
Phase 2 clinical trial update for a bisantrene combination in resistant acute myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sheba Medical Center | Conditions: Myelogenous Leukemia, Acute | Phase 2 | Status: UNKNOWN